nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomitapide—P-Glycoprotein Inhibitors—Vemurafenib—melanoma	0.717	1	CiPCiCtD
Lomitapide—ABCB1—melanoma	0.132	1	CbGaD
Lomitapide—CYP3A4—Temozolomide—melanoma	0.036	0.376	CbGbCtD
Lomitapide—ABCB1—Dactinomycin—melanoma	0.0219	0.229	CbGbCtD
Lomitapide—CYP3A4—Vemurafenib—melanoma	0.0197	0.206	CbGbCtD
Lomitapide—ABCB1—Docetaxel—melanoma	0.0113	0.118	CbGbCtD
Lomitapide—CYP3A4—Docetaxel—melanoma	0.00677	0.0708	CbGbCtD
Lomitapide—Hepatotoxicity—Vemurafenib—melanoma	0.000927	0.0229	CcSEcCtD
Lomitapide—Gamma-glutamyltransferase increased—Vemurafenib—melanoma	0.00087	0.0215	CcSEcCtD
Lomitapide—Reaction gastrointestinal—Docetaxel—melanoma	0.000729	0.018	CcSEcCtD
Lomitapide—Transaminases increased—Carmustine—melanoma	0.000622	0.0154	CcSEcCtD
Lomitapide—Hepatomegaly—Dactinomycin—melanoma	0.000572	0.0141	CcSEcCtD
Lomitapide—Hepatotoxicity—Dactinomycin—melanoma	0.000524	0.0129	CcSEcCtD
Lomitapide—Pain in extremity—Vemurafenib—melanoma	0.00052	0.0128	CcSEcCtD
Lomitapide—Hepatotoxicity—Carmustine—melanoma	0.00049	0.0121	CcSEcCtD
Lomitapide—Dry skin—Vemurafenib—melanoma	0.000476	0.0118	CcSEcCtD
Lomitapide—Hepatotoxicity—Temozolomide—melanoma	0.000474	0.0117	CcSEcCtD
Lomitapide—Gamma-glutamyltransferase increased—Temozolomide—melanoma	0.000445	0.011	CcSEcCtD
Lomitapide—Drug interaction—Carmustine—melanoma	0.000408	0.0101	CcSEcCtD
Lomitapide—Weight decreased—Vemurafenib—melanoma	0.000406	0.01	CcSEcCtD
Lomitapide—Infestation NOS—Vemurafenib—melanoma	0.000401	0.00989	CcSEcCtD
Lomitapide—Infestation—Vemurafenib—melanoma	0.000401	0.00989	CcSEcCtD
Lomitapide—Gait disturbance—Carmustine—melanoma	0.000388	0.00958	CcSEcCtD
Lomitapide—Hepatic enzyme increased—Temozolomide—melanoma	0.000387	0.00956	CcSEcCtD
Lomitapide—Gait disturbance—Temozolomide—melanoma	0.000375	0.00926	CcSEcCtD
Lomitapide—Pharyngolaryngeal pain—Docetaxel—melanoma	0.000361	0.0089	CcSEcCtD
Lomitapide—Laryngeal pain—Docetaxel—melanoma	0.000357	0.00882	CcSEcCtD
Lomitapide—Connective tissue disorder—Vemurafenib—melanoma	0.000353	0.00873	CcSEcCtD
Lomitapide—Antrafenine—PTGS2—melanoma	0.000337	0.751	CrCbGaD
Lomitapide—Eye disorder—Vemurafenib—melanoma	0.000336	0.0083	CcSEcCtD
Lomitapide—Cardiac disorder—Vemurafenib—melanoma	0.000334	0.00824	CcSEcCtD
Lomitapide—Mediastinal disorder—Vemurafenib—melanoma	0.000324	0.008	CcSEcCtD
Lomitapide—Chills—Vemurafenib—melanoma	0.000323	0.00797	CcSEcCtD
Lomitapide—Rash erythematous—Docetaxel—melanoma	0.000318	0.00785	CcSEcCtD
Lomitapide—Hepatotoxicity—Docetaxel—melanoma	0.000315	0.00778	CcSEcCtD
Lomitapide—Malnutrition—Vemurafenib—melanoma	0.000313	0.00773	CcSEcCtD
Lomitapide—Blood alkaline phosphatase increased—Temozolomide—melanoma	0.000305	0.00754	CcSEcCtD
Lomitapide—Back pain—Vemurafenib—melanoma	0.000303	0.00748	CcSEcCtD
Lomitapide—Gastroenteritis—Temozolomide—melanoma	0.0003	0.0074	CcSEcCtD
Lomitapide—Nasal congestion—Temozolomide—melanoma	0.000292	0.0072	CcSEcCtD
Lomitapide—Liver function test abnormal—Dactinomycin—melanoma	0.000271	0.0067	CcSEcCtD
Lomitapide—Myalgia—Vemurafenib—melanoma	0.000266	0.00658	CcSEcCtD
Lomitapide—Arthralgia—Vemurafenib—melanoma	0.000266	0.00658	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.000265	0.00654	CcSEcCtD
Lomitapide—Aspartate aminotransferase increased—Dactinomycin—melanoma	0.000264	0.00653	CcSEcCtD
Lomitapide—Drug interaction—Docetaxel—melanoma	0.000262	0.00648	CcSEcCtD
Lomitapide—Blood bilirubin increased—Docetaxel—melanoma	0.000257	0.00635	CcSEcCtD
Lomitapide—Infection—Vemurafenib—melanoma	0.000254	0.00627	CcSEcCtD
Lomitapide—Liver function test abnormal—Carmustine—melanoma	0.000254	0.00627	CcSEcCtD
Lomitapide—Nervous system disorder—Vemurafenib—melanoma	0.000251	0.00619	CcSEcCtD
Lomitapide—Skin disorder—Vemurafenib—melanoma	0.000248	0.00613	CcSEcCtD
Lomitapide—Dehydration—Temozolomide—melanoma	0.000247	0.0061	CcSEcCtD
Lomitapide—Weight decreased—Bleomycin—melanoma	0.000246	0.00608	CcSEcCtD
Lomitapide—Dry skin—Temozolomide—melanoma	0.000243	0.00601	CcSEcCtD
Lomitapide—Aspartate aminotransferase increased—Temozolomide—melanoma	0.000239	0.00591	CcSEcCtD
Lomitapide—Alanine aminotransferase increased—Temozolomide—melanoma	0.000234	0.00579	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000233	0.00575	CcSEcCtD
Lomitapide—Haematuria—Bleomycin—melanoma	0.000231	0.00571	CcSEcCtD
Lomitapide—Abdominal distension—Temozolomide—melanoma	0.000231	0.00571	CcSEcCtD
Lomitapide—Decreased appetite—Vemurafenib—melanoma	0.000222	0.00548	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Vemurafenib—melanoma	0.000221	0.00545	CcSEcCtD
Lomitapide—Fatigue—Vemurafenib—melanoma	0.00022	0.00544	CcSEcCtD
Lomitapide—Constipation—Vemurafenib—melanoma	0.000218	0.0054	CcSEcCtD
Lomitapide—Weight decreased—Temozolomide—melanoma	0.000208	0.00513	CcSEcCtD
Lomitapide—Infestation—Temozolomide—melanoma	0.000205	0.00506	CcSEcCtD
Lomitapide—Infestation NOS—Temozolomide—melanoma	0.000205	0.00506	CcSEcCtD
Lomitapide—Blood alkaline phosphatase increased—Docetaxel—melanoma	0.000203	0.00502	CcSEcCtD
Lomitapide—Body temperature increased—Vemurafenib—melanoma	0.000202	0.00499	CcSEcCtD
Lomitapide—Chills—Bleomycin—melanoma	0.000195	0.00483	CcSEcCtD
Lomitapide—Hepatobiliary disease—Temozolomide—melanoma	0.000194	0.00478	CcSEcCtD
Lomitapide—Sinusitis—Temozolomide—melanoma	0.000192	0.00474	CcSEcCtD
Lomitapide—Connective tissue disorder—Carmustine—melanoma	0.000187	0.00462	CcSEcCtD
Lomitapide—Dermatitis bullous—Docetaxel—melanoma	0.000185	0.00457	CcSEcCtD
Lomitapide—Asthenia—Vemurafenib—melanoma	0.000183	0.00453	CcSEcCtD
Lomitapide—Chills—Dactinomycin—melanoma	0.000182	0.0045	CcSEcCtD
Lomitapide—Urinary tract disorder—Temozolomide—melanoma	0.000181	0.00448	CcSEcCtD
Lomitapide—Connective tissue disorder—Temozolomide—melanoma	0.000181	0.00446	CcSEcCtD
Lomitapide—Urethral disorder—Temozolomide—melanoma	0.00018	0.00445	CcSEcCtD
Lomitapide—Eye disorder—Carmustine—melanoma	0.000178	0.00439	CcSEcCtD
Lomitapide—Pain in extremity—Docetaxel—melanoma	0.000177	0.00436	CcSEcCtD
Lomitapide—Ill-defined disorder—Bleomycin—melanoma	0.000176	0.00435	CcSEcCtD
Lomitapide—Anaemia—Bleomycin—melanoma	0.000175	0.00433	CcSEcCtD
Lomitapide—Diarrhoea—Vemurafenib—melanoma	0.000175	0.00432	CcSEcCtD
Lomitapide—Migraine—Docetaxel—melanoma	0.000174	0.00429	CcSEcCtD
Lomitapide—MTTP—Circadian rythm related genes—NGFR—melanoma	0.000172	0.012	CbGpPWpGaD
Lomitapide—Eye disorder—Temozolomide—melanoma	0.000172	0.00424	CcSEcCtD
Lomitapide—Malaise—Bleomycin—melanoma	0.000171	0.00422	CcSEcCtD
Lomitapide—Cardiac disorder—Temozolomide—melanoma	0.000171	0.00421	CcSEcCtD
Lomitapide—Dizziness—Vemurafenib—melanoma	0.000169	0.00417	CcSEcCtD
Lomitapide—Mediastinal disorder—Temozolomide—melanoma	0.000166	0.00409	CcSEcCtD
Lomitapide—Malnutrition—Carmustine—melanoma	0.000166	0.00409	CcSEcCtD
Lomitapide—Chills—Temozolomide—melanoma	0.000165	0.00407	CcSEcCtD
Lomitapide—Dehydration—Docetaxel—melanoma	0.000164	0.00406	CcSEcCtD
Lomitapide—Ill-defined disorder—Dactinomycin—melanoma	0.000164	0.00405	CcSEcCtD
Lomitapide—Anaemia—Dactinomycin—melanoma	0.000163	0.00404	CcSEcCtD
Lomitapide—Liver function test abnormal—Docetaxel—melanoma	0.000163	0.00403	CcSEcCtD
Lomitapide—Vomiting—Vemurafenib—melanoma	0.000162	0.00401	CcSEcCtD
Lomitapide—Dry skin—Docetaxel—melanoma	0.000162	0.004	CcSEcCtD
Lomitapide—Chest pain—Bleomycin—melanoma	0.000161	0.00399	CcSEcCtD
Lomitapide—Myalgia—Bleomycin—melanoma	0.000161	0.00399	CcSEcCtD
Lomitapide—Abdominal pain upper—Docetaxel—melanoma	0.000161	0.00398	CcSEcCtD
Lomitapide—Back pain—Carmustine—melanoma	0.00016	0.00395	CcSEcCtD
Lomitapide—Headache—Vemurafenib—melanoma	0.00016	0.00395	CcSEcCtD
Lomitapide—Malnutrition—Temozolomide—melanoma	0.00016	0.00395	CcSEcCtD
Lomitapide—Discomfort—Bleomycin—melanoma	0.00016	0.00394	CcSEcCtD
Lomitapide—Malaise—Dactinomycin—melanoma	0.00016	0.00394	CcSEcCtD
Lomitapide—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000159	0.00393	CcSEcCtD
Lomitapide—Nasopharyngitis—Docetaxel—melanoma	0.000158	0.0039	CcSEcCtD
Lomitapide—Alanine aminotransferase increased—Docetaxel—melanoma	0.000156	0.00385	CcSEcCtD
Lomitapide—Back pain—Temozolomide—melanoma	0.000155	0.00382	CcSEcCtD
Lomitapide—Infection—Bleomycin—melanoma	0.000154	0.0038	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—CUBN—melanoma	0.000154	0.0107	CbGpPWpGaD
Lomitapide—Anaemia—Carmustine—melanoma	0.000153	0.00378	CcSEcCtD
Lomitapide—Nausea—Vemurafenib—melanoma	0.000152	0.00375	CcSEcCtD
Lomitapide—Myalgia—Dactinomycin—melanoma	0.000151	0.00372	CcSEcCtD
Lomitapide—Discomfort—Dactinomycin—melanoma	0.000149	0.00367	CcSEcCtD
Lomitapide—Angina pectoris—Docetaxel—melanoma	0.000149	0.00367	CcSEcCtD
Lomitapide—Ill-defined disorder—Temozolomide—melanoma	0.000148	0.00367	CcSEcCtD
Lomitapide—Anaemia—Temozolomide—melanoma	0.000148	0.00365	CcSEcCtD
Lomitapide—CYP3A4—Liver X Receptor Pathway—FASN—melanoma	0.000146	0.0102	CbGpPWpGaD
Lomitapide—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—melanoma	0.000145	0.0101	CbGpPWpGaD
Lomitapide—Malaise—Temozolomide—melanoma	0.000144	0.00356	CcSEcCtD
Lomitapide—Vertigo—Temozolomide—melanoma	0.000144	0.00355	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—GPAM—melanoma	0.000144	0.00998	CbGpPWpGaD
Lomitapide—Infection—Dactinomycin—melanoma	0.000143	0.00354	CcSEcCtD
Lomitapide—Palpitations—Temozolomide—melanoma	0.000141	0.00349	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Bleomycin—melanoma	0.000141	0.00348	CcSEcCtD
Lomitapide—Chest pain—Carmustine—melanoma	0.000141	0.00348	CcSEcCtD
Lomitapide—Myalgia—Carmustine—melanoma	0.000141	0.00348	CcSEcCtD
Lomitapide—Paraesthesia—Bleomycin—melanoma	0.000139	0.00343	CcSEcCtD
Lomitapide—Weight decreased—Docetaxel—melanoma	0.000138	0.00341	CcSEcCtD
Lomitapide—Arthralgia—Temozolomide—melanoma	0.000136	0.00336	CcSEcCtD
Lomitapide—Myalgia—Temozolomide—melanoma	0.000136	0.00336	CcSEcCtD
Lomitapide—Infestation—Docetaxel—melanoma	0.000136	0.00336	CcSEcCtD
Lomitapide—Infestation NOS—Docetaxel—melanoma	0.000136	0.00336	CcSEcCtD
Lomitapide—MTTP—Metabolism—ACER3—melanoma	0.000135	0.0094	CbGpPWpGaD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000135	0.00334	CcSEcCtD
Lomitapide—Discomfort—Temozolomide—melanoma	0.000135	0.00332	CcSEcCtD
Lomitapide—Decreased appetite—Bleomycin—melanoma	0.000135	0.00332	CcSEcCtD
Lomitapide—Infection—Carmustine—melanoma	0.000134	0.00332	CcSEcCtD
Lomitapide—Dry mouth—Temozolomide—melanoma	0.000133	0.00329	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000132	0.00325	CcSEcCtD
Lomitapide—CYP3A4—Codeine and Morphine Metabolism—ABCB1—melanoma	0.000131	0.00911	CbGpPWpGaD
Lomitapide—Infection—Temozolomide—melanoma	0.00013	0.0032	CcSEcCtD
Lomitapide—Hepatobiliary disease—Docetaxel—melanoma	0.000129	0.00318	CcSEcCtD
Lomitapide—MTTP—Circadian rythm related genes—FAS—melanoma	0.000128	0.00892	CbGpPWpGaD
Lomitapide—Nervous system disorder—Temozolomide—melanoma	0.000128	0.00316	CcSEcCtD
Lomitapide—Feeling abnormal—Bleomycin—melanoma	0.000128	0.00315	CcSEcCtD
Lomitapide—Skin disorder—Temozolomide—melanoma	0.000127	0.00313	CcSEcCtD
Lomitapide—Hyperhidrosis—Temozolomide—melanoma	0.000126	0.00312	CcSEcCtD
Lomitapide—Decreased appetite—Dactinomycin—melanoma	0.000125	0.0031	CcSEcCtD
Lomitapide—Fatigue—Dactinomycin—melanoma	0.000124	0.00307	CcSEcCtD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—ARNT—melanoma	0.000124	0.00863	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—UGT2B10—melanoma	0.000124	0.00859	CbGpPWpGaD
Lomitapide—Musculoskeletal discomfort—Carmustine—melanoma	0.000123	0.00304	CcSEcCtD
Lomitapide—Body temperature increased—Bleomycin—melanoma	0.000122	0.00302	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	0.000122	0.00848	CbGpPWpGaD
Lomitapide—Paraesthesia—Carmustine—melanoma	0.000121	0.003	CcSEcCtD
Lomitapide—Urinary tract disorder—Docetaxel—melanoma	0.000121	0.00298	CcSEcCtD
Lomitapide—Somnolence—Carmustine—melanoma	0.00012	0.00297	CcSEcCtD
Lomitapide—Connective tissue disorder—Docetaxel—melanoma	0.00012	0.00297	CcSEcCtD
Lomitapide—Urethral disorder—Docetaxel—melanoma	0.00012	0.00296	CcSEcCtD
Lomitapide—Feeling abnormal—Dactinomycin—melanoma	0.000119	0.00294	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Temozolomide—melanoma	0.000119	0.00294	CcSEcCtD
Lomitapide—Gastrointestinal pain—Dactinomycin—melanoma	0.000118	0.00292	CcSEcCtD
Lomitapide—Decreased appetite—Carmustine—melanoma	0.000117	0.0029	CcSEcCtD
Lomitapide—Paraesthesia—Temozolomide—melanoma	0.000117	0.0029	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Carmustine—melanoma	0.000117	0.00288	CcSEcCtD
Lomitapide—ABCB1—Drug Induction of Bile Acid Pathway—VDR—melanoma	0.000116	0.00807	CbGpPWpGaD
Lomitapide—Somnolence—Temozolomide—melanoma	0.000116	0.00287	CcSEcCtD
Lomitapide—Constipation—Carmustine—melanoma	0.000116	0.00285	CcSEcCtD
Lomitapide—MTTP—Metabolism—HS3ST5—melanoma	0.000115	0.00799	CbGpPWpGaD
Lomitapide—Dyspepsia—Temozolomide—melanoma	0.000115	0.00284	CcSEcCtD
Lomitapide—Eye disorder—Docetaxel—melanoma	0.000114	0.00282	CcSEcCtD
Lomitapide—Abdominal pain—Dactinomycin—melanoma	0.000114	0.00282	CcSEcCtD
Lomitapide—Body temperature increased—Dactinomycin—melanoma	0.000114	0.00282	CcSEcCtD
Lomitapide—Decreased appetite—Temozolomide—melanoma	0.000113	0.0028	CcSEcCtD
Lomitapide—Cardiac disorder—Docetaxel—melanoma	0.000113	0.0028	CcSEcCtD
Lomitapide—MTTP—Circadian rythm related genes—CDK4—melanoma	0.000113	0.00785	CbGpPWpGaD
Lomitapide—Gastrointestinal disorder—Temozolomide—melanoma	0.000113	0.00278	CcSEcCtD
Lomitapide—Fatigue—Temozolomide—melanoma	0.000113	0.00278	CcSEcCtD
Lomitapide—Fexofenadine—ABCB1—melanoma	0.000112	0.249	CrCbGaD
Lomitapide—Constipation—Temozolomide—melanoma	0.000112	0.00276	CcSEcCtD
Lomitapide—Feeling abnormal—Carmustine—melanoma	0.000111	0.00275	CcSEcCtD
Lomitapide—Asthenia—Bleomycin—melanoma	0.000111	0.00274	CcSEcCtD
Lomitapide—Gastrointestinal pain—Carmustine—melanoma	0.00011	0.00273	CcSEcCtD
Lomitapide—Mediastinal disorder—Docetaxel—melanoma	0.00011	0.00272	CcSEcCtD
Lomitapide—MTTP—Circadian rythm related genes—NOS2—melanoma	0.00011	0.00763	CbGpPWpGaD
Lomitapide—Chills—Docetaxel—melanoma	0.00011	0.00271	CcSEcCtD
Lomitapide—Feeling abnormal—Temozolomide—melanoma	0.000108	0.00266	CcSEcCtD
Lomitapide—Body temperature increased—Carmustine—melanoma	0.000107	0.00264	CcSEcCtD
Lomitapide—Abdominal pain—Carmustine—melanoma	0.000107	0.00264	CcSEcCtD
Lomitapide—Gastrointestinal pain—Temozolomide—melanoma	0.000107	0.00264	CcSEcCtD
Lomitapide—Malnutrition—Docetaxel—melanoma	0.000106	0.00263	CcSEcCtD
Lomitapide—Asthenia—Dactinomycin—melanoma	0.000104	0.00256	CcSEcCtD
Lomitapide—Body temperature increased—Temozolomide—melanoma	0.000103	0.00255	CcSEcCtD
Lomitapide—Abdominal pain—Temozolomide—melanoma	0.000103	0.00255	CcSEcCtD
Lomitapide—Back pain—Docetaxel—melanoma	0.000103	0.00254	CcSEcCtD
Lomitapide—MTTP—Circadian rythm related genes—PPARG—melanoma	0.000103	0.00713	CbGpPWpGaD
Lomitapide—Muscle spasms—Docetaxel—melanoma	0.000102	0.00253	CcSEcCtD
Lomitapide—Diarrhoea—Dactinomycin—melanoma	9.88e-05	0.00244	CcSEcCtD
Lomitapide—Vomiting—Bleomycin—melanoma	9.84e-05	0.00243	CcSEcCtD
Lomitapide—Anaemia—Docetaxel—melanoma	9.83e-05	0.00243	CcSEcCtD
Lomitapide—Asthenia—Carmustine—melanoma	9.69e-05	0.00239	CcSEcCtD
Lomitapide—Palpitations—Docetaxel—melanoma	9.4e-05	0.00232	CcSEcCtD
Lomitapide—Asthenia—Temozolomide—melanoma	9.37e-05	0.00231	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	9.26e-05	0.00643	CbGpPWpGaD
Lomitapide—Diarrhoea—Carmustine—melanoma	9.24e-05	0.00228	CcSEcCtD
Lomitapide—Nausea—Bleomycin—melanoma	9.19e-05	0.00227	CcSEcCtD
Lomitapide—Vomiting—Dactinomycin—melanoma	9.18e-05	0.00227	CcSEcCtD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—NDRG1—melanoma	9.09e-05	0.00632	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—MCL1—melanoma	9.09e-05	0.00632	CbGpPWpGaD
Lomitapide—Myalgia—Docetaxel—melanoma	9.06e-05	0.00224	CcSEcCtD
Lomitapide—Chest pain—Docetaxel—melanoma	9.06e-05	0.00224	CcSEcCtD
Lomitapide—Arthralgia—Docetaxel—melanoma	9.06e-05	0.00224	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	9e-05	0.00222	CcSEcCtD
Lomitapide—Dizziness—Carmustine—melanoma	8.93e-05	0.00221	CcSEcCtD
Lomitapide—Diarrhoea—Temozolomide—melanoma	8.93e-05	0.00221	CcSEcCtD
Lomitapide—Dry mouth—Docetaxel—melanoma	8.86e-05	0.00219	CcSEcCtD
Lomitapide—MTTP—Metabolism—PLCB4—melanoma	8.72e-05	0.00605	CbGpPWpGaD
Lomitapide—Dizziness—Temozolomide—melanoma	8.63e-05	0.00213	CcSEcCtD
Lomitapide—Infection—Docetaxel—melanoma	8.63e-05	0.00213	CcSEcCtD
Lomitapide—Vomiting—Carmustine—melanoma	8.59e-05	0.00212	CcSEcCtD
Lomitapide—Nausea—Dactinomycin—melanoma	8.57e-05	0.00212	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—FASN—melanoma	8.56e-05	0.00594	CbGpPWpGaD
Lomitapide—Nervous system disorder—Docetaxel—melanoma	8.51e-05	0.0021	CcSEcCtD
Lomitapide—Headache—Carmustine—melanoma	8.46e-05	0.00209	CcSEcCtD
Lomitapide—Skin disorder—Docetaxel—melanoma	8.43e-05	0.00208	CcSEcCtD
Lomitapide—CYP3A4—Estrogen metabolism—CYP1B1—melanoma	8.32e-05	0.00578	CbGpPWpGaD
Lomitapide—Vomiting—Temozolomide—melanoma	8.3e-05	0.00205	CcSEcCtD
Lomitapide—MTTP—Metabolism—SLC6A11—melanoma	8.2e-05	0.00569	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PIP4K2A—melanoma	8.2e-05	0.00569	CbGpPWpGaD
Lomitapide—Headache—Temozolomide—melanoma	8.18e-05	0.00202	CcSEcCtD
Lomitapide—Nausea—Carmustine—melanoma	8.03e-05	0.00198	CcSEcCtD
Lomitapide—MTTP—Metabolism—MTAP—melanoma	7.97e-05	0.00554	CbGpPWpGaD
Lomitapide—Musculoskeletal discomfort—Docetaxel—melanoma	7.91e-05	0.00195	CcSEcCtD
Lomitapide—Paraesthesia—Docetaxel—melanoma	7.8e-05	0.00193	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	7.79e-05	0.00541	CbGpPWpGaD
Lomitapide—Nausea—Temozolomide—melanoma	7.76e-05	0.00192	CcSEcCtD
Lomitapide—Somnolence—Docetaxel—melanoma	7.72e-05	0.00191	CcSEcCtD
Lomitapide—Dyspepsia—Docetaxel—melanoma	7.64e-05	0.00189	CcSEcCtD
Lomitapide—Decreased appetite—Docetaxel—melanoma	7.55e-05	0.00186	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Docetaxel—melanoma	7.5e-05	0.00185	CcSEcCtD
Lomitapide—Fatigue—Docetaxel—melanoma	7.49e-05	0.00185	CcSEcCtD
Lomitapide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—melanoma	7.44e-05	0.00517	CbGpPWpGaD
Lomitapide—Constipation—Docetaxel—melanoma	7.43e-05	0.00183	CcSEcCtD
Lomitapide—CYP3A4—Tamoxifen metabolism—CYP1B1—melanoma	7.36e-05	0.00511	CbGpPWpGaD
Lomitapide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—melanoma	7.17e-05	0.00498	CbGpPWpGaD
Lomitapide—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—melanoma	7.16e-05	0.00497	CbGpPWpGaD
Lomitapide—Feeling abnormal—Docetaxel—melanoma	7.16e-05	0.00177	CcSEcCtD
Lomitapide—MTTP—Metabolism—LUM—melanoma	7.11e-05	0.00494	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PHGDH—melanoma	7.11e-05	0.00494	CbGpPWpGaD
Lomitapide—Gastrointestinal pain—Docetaxel—melanoma	7.1e-05	0.00175	CcSEcCtD
Lomitapide—MTTP—Circadian rythm related genes—PTEN—melanoma	7.04e-05	0.00489	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—HPSE—melanoma	6.97e-05	0.00484	CbGpPWpGaD
Lomitapide—Abdominal pain—Docetaxel—melanoma	6.86e-05	0.0017	CcSEcCtD
Lomitapide—Body temperature increased—Docetaxel—melanoma	6.86e-05	0.0017	CcSEcCtD
Lomitapide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—melanoma	6.86e-05	0.00477	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—CUBN—melanoma	6.84e-05	0.00475	CbGpPWpGaD
Lomitapide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GAB2—melanoma	6.8e-05	0.00472	CbGpPWpGaD
Lomitapide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—melanoma	6.77e-05	0.0047	CbGpPWpGaD
Lomitapide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—melanoma	6.67e-05	0.00464	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—SDHD—melanoma	6.61e-05	0.00459	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—BSG—melanoma	6.61e-05	0.00459	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—CSPG4—melanoma	6.61e-05	0.00459	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—GPAM—melanoma	6.4e-05	0.00444	CbGpPWpGaD
Lomitapide—Asthenia—Docetaxel—melanoma	6.23e-05	0.00154	CcSEcCtD
Lomitapide—ABCB1—Allograft Rejection—FOXP3—melanoma	6.18e-05	0.00429	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—ETS1—melanoma	6.14e-05	0.00427	CbGpPWpGaD
Lomitapide—CYP3A4—Irinotecan Pathway—APC—melanoma	6.04e-05	0.0042	CbGpPWpGaD
Lomitapide—Diarrhoea—Docetaxel—melanoma	5.94e-05	0.00147	CcSEcCtD
Lomitapide—Dizziness—Docetaxel—melanoma	5.74e-05	0.00142	CcSEcCtD
Lomitapide—Vomiting—Docetaxel—melanoma	5.52e-05	0.00136	CcSEcCtD
Lomitapide—MTTP—Metabolism—PLA2G6—melanoma	5.44e-05	0.00378	CbGpPWpGaD
Lomitapide—Headache—Docetaxel—melanoma	5.44e-05	0.00134	CcSEcCtD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—EPO—melanoma	5.41e-05	0.00376	CbGpPWpGaD
Lomitapide—Nausea—Docetaxel—melanoma	5.16e-05	0.00127	CcSEcCtD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—CXCR4—melanoma	5.04e-05	0.0035	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—VCAN—melanoma	4.89e-05	0.00339	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—UGT2B10—melanoma	4.88e-05	0.00339	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CAPN1—melanoma	4.82e-05	0.00335	CbGpPWpGaD
Lomitapide—MTTP—Circadian rythm related genes—TP53—melanoma	4.81e-05	0.00334	CbGpPWpGaD
Lomitapide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	4.65e-05	0.00323	CbGpPWpGaD
Lomitapide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—melanoma	4.64e-05	0.00322	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	4.63e-05	0.00321	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PPARG—melanoma	4.46e-05	0.0031	CbGpPWpGaD
Lomitapide—MTTP—Circadian rythm related genes—IL6—melanoma	4.4e-05	0.00305	CbGpPWpGaD
Lomitapide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—melanoma	4.33e-05	0.003	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—CTLA4—melanoma	4.25e-05	0.00295	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—ABCB5—melanoma	4.17e-05	0.0029	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—CYP17A1—melanoma	4.12e-05	0.00286	CbGpPWpGaD
Lomitapide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—melanoma	4.12e-05	0.00286	CbGpPWpGaD
Lomitapide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—melanoma	4.11e-05	0.00286	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	4.07e-05	0.00282	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—ALB—melanoma	4.01e-05	0.00279	CbGpPWpGaD
Lomitapide—CYP3A4—Tryptophan metabolism—CYP1B1—melanoma	3.93e-05	0.00273	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—GNA11—melanoma	3.89e-05	0.0027	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—NODAL—melanoma	3.89e-05	0.0027	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—EDN1—melanoma	3.86e-05	0.00268	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—FASN—melanoma	3.81e-05	0.00265	CbGpPWpGaD
Lomitapide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—melanoma	3.77e-05	0.00262	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—SLC5A5—melanoma	3.75e-05	0.0026	CbGpPWpGaD
Lomitapide—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—melanoma	3.72e-05	0.00259	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—CD44—melanoma	3.62e-05	0.00251	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—GNAQ—melanoma	3.62e-05	0.00251	CbGpPWpGaD
Lomitapide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—melanoma	3.6e-05	0.0025	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	3.54e-05	0.00246	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PTGS2—melanoma	3.51e-05	0.00244	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—CYP1B1—melanoma	3.47e-05	0.00241	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—MAP3K5—melanoma	3.46e-05	0.00241	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP10—melanoma	3.46e-05	0.00241	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—CD86—melanoma	3.37e-05	0.00234	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—TERT—melanoma	3.37e-05	0.00234	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—IL10—melanoma	3.31e-05	0.0023	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—HIF1A—melanoma	3.22e-05	0.00224	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—IL4—melanoma	3.22e-05	0.00223	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—melanoma	3.2e-05	0.00222	CbGpPWpGaD
Lomitapide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	3.18e-05	0.00221	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—PDGFRA—melanoma	3.17e-05	0.0022	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—HLA-B—melanoma	3.15e-05	0.00218	CbGpPWpGaD
Lomitapide—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—melanoma	3.13e-05	0.00218	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—APAF1—melanoma	3.11e-05	0.00216	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—AKR1B10—melanoma	3.1e-05	0.00215	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—FASLG—melanoma	3.07e-05	0.00214	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.06e-05	0.00213	CbGpPWpGaD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	3.06e-05	0.00212	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—FAS—melanoma	2.97e-05	0.00206	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—melanoma	2.95e-05	0.00205	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—NOS2—melanoma	2.93e-05	0.00203	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—HLA-A—melanoma	2.91e-05	0.00202	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—ARL2—melanoma	2.89e-05	0.00201	CbGpPWpGaD
Lomitapide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	2.87e-05	0.00199	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—ABCB1—melanoma	2.86e-05	0.00198	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—HLA-DRB1—melanoma	2.66e-05	0.00185	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PRKCA—melanoma	2.63e-05	0.00183	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—ERCC2—melanoma	2.61e-05	0.00181	CbGpPWpGaD
Lomitapide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—melanoma	2.59e-05	0.0018	CbGpPWpGaD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	2.58e-05	0.00179	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—CD80—melanoma	2.46e-05	0.00171	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—CASP8—melanoma	2.29e-05	0.00159	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC15A2—melanoma	2.19e-05	0.00152	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.16e-05	0.0015	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC17A5—melanoma	2.11e-05	0.00146	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PIK3CG—melanoma	2.06e-05	0.00143	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PPARG—melanoma	1.99e-05	0.00138	CbGpPWpGaD
Lomitapide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—melanoma	1.98e-05	0.00138	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—IFNG—melanoma	1.94e-05	0.00135	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC6A11—melanoma	1.91e-05	0.00133	CbGpPWpGaD
Lomitapide—CYP3A4—Tryptophan metabolism—MDM2—melanoma	1.84e-05	0.00128	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PIK3CD—melanoma	1.81e-05	0.00126	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—CXCL8—melanoma	1.81e-05	0.00126	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—ALB—melanoma	1.79e-05	0.00124	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—CASP3—melanoma	1.73e-05	0.0012	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—IL2—melanoma	1.73e-05	0.0012	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—melanoma	1.72e-05	0.0012	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—melanoma	1.7e-05	0.00118	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—CYP17A1—melanoma	1.63e-05	0.00113	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	1.61e-05	0.00112	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	1.6e-05	0.00111	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	1.58e-05	0.0011	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PIK3CB—melanoma	1.58e-05	0.0011	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PTGS2—melanoma	1.56e-05	0.00109	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	1.56e-05	0.00109	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	1.55e-05	0.00107	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	1.52e-05	0.00105	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	1.49e-05	0.00103	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ACER3—melanoma	1.48e-05	0.00103	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—VEGFA—melanoma	1.47e-05	0.00102	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—melanoma	1.46e-05	0.00102	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	1.43e-05	0.000996	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—CYP1B1—melanoma	1.37e-05	0.00095	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PTEN—melanoma	1.36e-05	0.000947	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	1.36e-05	0.000946	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—UGT2B10—melanoma	1.35e-05	0.00094	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	1.35e-05	0.000937	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—melanoma	1.29e-05	0.000898	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	1.29e-05	0.000894	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—TNF—melanoma	1.26e-05	0.000874	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—HS3ST5—melanoma	1.26e-05	0.000874	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—APC—melanoma	1.21e-05	0.000842	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—melanoma	1.2e-05	0.000832	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	1.13e-05	0.000784	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	1.11e-05	0.000771	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—AKT1—melanoma	1.08e-05	0.000752	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	1.07e-05	0.000745	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	1.02e-05	0.000708	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	9.69e-06	0.000673	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PIK3CA—melanoma	9.62e-06	0.000668	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	9.55e-06	0.000663	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PLCB4—melanoma	9.54e-06	0.000662	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	9.41e-06	0.000654	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	9.2e-06	0.000639	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ACER3—melanoma	9.12e-06	0.000633	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PIP4K2A—melanoma	8.97e-06	0.000623	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—SLC6A11—melanoma	8.97e-06	0.000623	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC5A5—melanoma	8.76e-06	0.000608	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—MTAP—melanoma	8.72e-06	0.000606	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	8.72e-06	0.000605	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	8.54e-06	0.000593	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—UGT2B10—melanoma	8.34e-06	0.000579	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	8.31e-06	0.000577	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	8.23e-06	0.000572	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	8.04e-06	0.000559	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	8.02e-06	0.000557	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	7.99e-06	0.000555	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—AKT1—melanoma	7.86e-06	0.000546	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—LUM—melanoma	7.77e-06	0.00054	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PHGDH—melanoma	7.77e-06	0.00054	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—HS3ST5—melanoma	7.75e-06	0.000538	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—HPSE—melanoma	7.62e-06	0.00053	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CUBN—melanoma	7.48e-06	0.00052	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	7.25e-06	0.000503	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—BSG—melanoma	7.23e-06	0.000502	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—SDHD—melanoma	7.23e-06	0.000502	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CSPG4—melanoma	7.23e-06	0.000502	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GPAM—melanoma	7e-06	0.000486	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	6.86e-06	0.000476	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	6.67e-06	0.000463	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	6.52e-06	0.000453	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	6.52e-06	0.000453	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	6.21e-06	0.000431	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	6.16e-06	0.000428	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PLA2G6—melanoma	5.95e-06	0.000413	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PLCB4—melanoma	5.88e-06	0.000408	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	5.66e-06	0.000393	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PIP4K2A—melanoma	5.52e-06	0.000384	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—SLC6A11—melanoma	5.52e-06	0.000384	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	5.48e-06	0.00038	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—MTAP—melanoma	5.37e-06	0.000373	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—VCAN—melanoma	5.35e-06	0.000371	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PHGDH—melanoma	4.79e-06	0.000333	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—LUM—melanoma	4.79e-06	0.000333	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—HPSE—melanoma	4.7e-06	0.000326	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	4.62e-06	0.000321	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CUBN—melanoma	4.61e-06	0.00032	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CYP17A1—melanoma	4.51e-06	0.000313	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—SDHD—melanoma	4.45e-06	0.000309	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—BSG—melanoma	4.45e-06	0.000309	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CSPG4—melanoma	4.45e-06	0.000309	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GPAM—melanoma	4.31e-06	0.0003	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GNA11—melanoma	4.26e-06	0.000296	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	4.18e-06	0.00029	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—FASN—melanoma	4.17e-06	0.00029	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—SLC5A5—melanoma	4.1e-06	0.000285	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CD44—melanoma	3.96e-06	0.000275	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GNAQ—melanoma	3.96e-06	0.000275	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CYP1B1—melanoma	3.8e-06	0.000264	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PLA2G6—melanoma	3.67e-06	0.000255	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—VCAN—melanoma	3.29e-06	0.000229	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PRKCA—melanoma	2.88e-06	0.0002	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ERCC2—melanoma	2.85e-06	0.000198	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CYP17A1—melanoma	2.78e-06	0.000193	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GNA11—melanoma	2.62e-06	0.000182	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—FASN—melanoma	2.57e-06	0.000178	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—SLC5A5—melanoma	2.53e-06	0.000175	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CD44—melanoma	2.44e-06	0.000169	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GNAQ—melanoma	2.44e-06	0.000169	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CYP1B1—melanoma	2.34e-06	0.000162	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PIK3CG—melanoma	2.25e-06	0.000157	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PPARG—melanoma	2.18e-06	0.000151	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PIK3CD—melanoma	1.98e-06	0.000138	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ALB—melanoma	1.96e-06	0.000136	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ABCB1—melanoma	1.93e-06	0.000134	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PRKCA—melanoma	1.77e-06	0.000123	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ERCC2—melanoma	1.76e-06	0.000122	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PIK3CB—melanoma	1.73e-06	0.00012	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PTGS2—melanoma	1.71e-06	0.000119	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PTEN—melanoma	1.49e-06	0.000104	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PIK3CG—melanoma	1.39e-06	9.64e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PPARG—melanoma	1.34e-06	9.31e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PIK3CD—melanoma	1.22e-06	8.48e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ALB—melanoma	1.21e-06	8.37e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PIK3CB—melanoma	1.06e-06	7.39e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PTGS2—melanoma	1.05e-06	7.32e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PIK3CA—melanoma	1.05e-06	7.31e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PTEN—melanoma	9.19e-07	6.39e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—AKT1—melanoma	8.6e-07	5.97e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PIK3CA—melanoma	6.49e-07	4.5e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—AKT1—melanoma	5.3e-07	3.68e-05	CbGpPWpGaD
